Larson Financial Group
RCUS icon

Larson Financial Group’s Arcus Biosciences RCUS Stock Holding History

Larson Financial Group’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$594 Hold
23
– – ﹤0.01% 3542
2026
Q2 		$709 Buy
23
+2
+10% +$49 ﹤0.01% 3410
2026
Q1 		$454 Sell
21
-9
-30% -$194 ﹤0.01% 3329
2025
Q4 		$715 Buy
30
+18
+150% +$367 ﹤0.01% 3036
2025
Q3 		$163 Sell
12
-5
-29% -$52 ﹤0.01% 3283
2025
Q2 		$138 Buy
+17
New +$145 ﹤0.01% 3125

Other funds holding RCUS

Gilead Sciences
Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Larson Financial Group's RCUS Position: Q3 2026 in Review

Larson Financial Group held its Arcus Biosciences (RCUS) position steady in Q3 2026 at 23 shares worth $594. The position accounts for ﹤0.01% of the portfolio, ranked #3542.

Larson Financial Group first reported a position in RCUS in Q2 2025 and has held it in 6 quarters since. The position peaked at $715 in Q4 2025. 92 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

  • Larson Financial Group held 23 shares of Arcus Biosciences worth $594 as of Q3 2026.
  • Larson Financial Group left its Arcus Biosciences share count unchanged in Q3 2026.
  • Arcus Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3542 holding.
  • Larson Financial Group first reported a position in Arcus Biosciences in Q2 2025 and has held it in 6 quarters since.
  • Larson Financial Group's Arcus Biosciences position peaked at $715 in Q4 2025.
  • 92 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.